文献速递泌尿生殖腹部MR

体素内不相干运动MRI评估前列腺癌肿瘤缺氧

Assessing tumor hypoxia in prostate cancer using intravoxel incoherent motion: a hypothesis-generating study.
PubMed 文献 · Clin Radiol · 2026-06-16

本研究回顾性纳入67例前列腺癌或可疑病变患者,分析IVIM参数与HIF-1α免疫组化标记的肿瘤缺氧状态的关系。结果显示缺氧阳性病灶的扩散系数D显著更低,FD亦较低。初步提示IVIM可能作为预测前列腺癌缺氧和侵袭性的无创生物标志物。

要点

  • 缺氧阳性前列腺癌病灶IVIM扩散系数D显著低于阴性病灶
  • 缺氧更多见于ISUP 3-5级及NCCN风险分层更高的肿瘤
  • IVIM参数有望作为预测前列腺癌侵袭性的无创影像指标

核心结论

  • IVIM可能作为预测前列腺癌肿瘤缺氧和侵袭性的无创生物标志物,但需前瞻性研究进一步验证。

研究设计与样本

  • 多参数MRI采集IVIM序列,使用3D Slicer软件分别勾画肿瘤区与正常外周带,MATLAB提取IVIM参数。
  • 以抗HIF-1α抗体免疫组化染色判断肿瘤缺氧状态,由独立放射科医师比对病理与MRI数据。

关键影像表现/征象

  • 缺氧阳性前列腺癌病灶的IVIM扩散系数D显著低于缺氧阴性病灶(p=0.02)。
  • 缺氧阳性病灶的血流相关参数FD亦较低,差异呈临界显著性(p=0.05)。
  • 两组间平均年龄、PSA、dPSA及前列腺体积无显著差异,影像差异主要见于扩散相关参数。

诊断标准与关键数值

  • HIF-1α免疫组化阳性判定为缺氧,67例中34例阳性、33例阴性。
  • 缺氧组与无缺氧组比较,扩散系数D差异有统计学意义(p=0.02)。
  • 血流相关参数FD组间差异呈临界显著性(p=0.05)。
  • 缺氧在ISUP 3-5级肿瘤中占比79.3%,高于ISUP 1-2级的54.6%(p=0.02)。
  • 缺氧与更差的NCCN风险分层相关(p=0.002)。

临床应用与阅片要点

  • 阅片时可关注前列腺癌病灶IVIM扩散系数D明显减低者,提示缺氧及更高侵袭性可能。
  • 缺氧阳性更常见于ISUP 3-5级和NCCN高风险肿瘤,报告可结合IVIM参数提示病理升级风险。
  • 当前IVIM评估缺氧仍属探索性应用,不应单独作为临床决策依据。

局限性

  • 回顾性单中心研究设计,存在选择偏倚可能。
  • 样本量有限,仅67例患者,组间比较的统计效能受限。
  • FD组间差异仅为临界显著性,结论的稳健性有待更大样本验证。
  • 缺乏外部验证,IVIM参数诊断缺氧的阈值和可重复性未明确。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

AIM: Hypoxia plays a key role in tumor aggressiveness and progression in prostate cancer (PCa). However, current methods for detecting tumor hypoxia in PCa are either invasive or suboptimal. This study investigates the use of Intravoxel Incoherent Motion (IVIM) in Magnetic Resonance Imaging (MRI) as a noninvasive approach to detect tumor hypoxia in PCa.

MATERIALS AND METHODS: This retrospective study included 67 consecutive patients diagnosed with PCa or suspicious lesions (Prostate Imaging Reporting and Data System [PI-RADS] scores 3, 4, 5) on multiparametric MRI between November 2019 and February 2021. IVIM images were analyzed, and tumor and normal peripheral zones were segmented separately using 3D slicer software (version 4.10.2). IVIM parameters, including diffusion coefficient (D), blood flow-related parameter (FD), pseudodiffusion coefficient (D∗), and perfusion fraction (f), were extracted using MATLAB. Tumor sections were stained with anti-HIF-1α antibody to determine hypoxia status. Pathological findings were compared with MRI data by an independent radiologist.

RESULTS: Of the 67 patients, 33 were HIF-1α negative, while 34 were positive. No significant differences were found in mean age, prostate-specific antigen (PSA), density of prostate-specific antigen (dPSA), or prostate volume between groups. However, hypoxia-positive lesions had significantly lower diffusion map values (p=0.02). Blood flow-related parameter (FD) values were also lower, with borderline significance (p=0.05). Hypoxia was more prevalent in International Society of Urological Pathology (ISUP) tumor grades 3-5 tumors (79.3% vs 54.6%, p=0.02) and was associated with worse National Comprehensive Cancer Network (NCCN) risk stratification (p=0.002).

CONCLUSIONS: Preliminary findings suggest IVIM may serve as a noninvasive biomarker for predicting tumor hypoxia and PCa aggressiveness. Further validation in prospective studies is needed.

来源:Clin Radiol,查看原文。版权归原作者所有。

引用

  1. Alagbe, Pascoal, Chahud, et al. Assessing tumor hypoxia in prostate cancer using intravoxel incoherent motion: a hypothesis-generating study. Clin Radiol. 2026. PMID: 42424761. doi:10.1016/j.crad.2026.107408

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。